table of content
1 Introduction to Research & Analysis Reports
1.1 mRNA Cancer Vaccines and Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global mRNA Cancer Vaccines and Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global mRNA Cancer Vaccines and Therapeutics Overall Market Size
2.1 Global mRNA Cancer Vaccines and Therapeutics Market Size: 2022 VS 2030
2.2 Global mRNA Cancer Vaccines and Therapeutics Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top mRNA Cancer Vaccines and Therapeutics Players in Global Market
3.2 Top Global mRNA Cancer Vaccines and Therapeutics Companies Ranked by Revenue
3.3 Global mRNA Cancer Vaccines and Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 mRNA Cancer Vaccines and Therapeutics Companies in Global Market, by Revenue in 2022
3.5 Global Companies mRNA Cancer Vaccines and Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 mRNA Cancer Vaccines and Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 mRNA Cancer Vaccines and Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 mRNA Cancer Vaccines and Therapeutics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global mRNA Cancer Vaccines and Therapeutics Market Size Markets, 2022 & 2030
4.1.2 Standardization Of Cancer Treatment MRNA Vaccine
4.1.3 Individualized Cancer Treatment MRNA Vaccine
4.1.4 Infectious Disease Treatment MRNA Vaccine
4.1.5 Infection Prevention MRNA Vaccine
4.2 By Type - Global mRNA Cancer Vaccines and Therapeutics Revenue & Forecasts
4.2.1 By Type - Global mRNA Cancer Vaccines and Therapeutics Revenue, 2018-2023
4.2.2 By Type - Global mRNA Cancer Vaccines and Therapeutics Revenue, 2024-2030
4.2.3 By Type - Global mRNA Cancer Vaccines and Therapeutics Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global mRNA Cancer Vaccines and Therapeutics Market Size, 2022 & 2030
5.1.2 Infectious Disease
5.1.3 Cancer
5.1.4 Other
5.2 By Application - Global mRNA Cancer Vaccines and Therapeutics Revenue & Forecasts
5.2.1 By Application - Global mRNA Cancer Vaccines and Therapeutics Revenue, 2018-2023
5.2.2 By Application - Global mRNA Cancer Vaccines and Therapeutics Revenue, 2024-2030
5.2.3 By Application - Global mRNA Cancer Vaccines and Therapeutics Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global mRNA Cancer Vaccines and Therapeutics Market Size, 2022 & 2030
6.2 By Region - Global mRNA Cancer Vaccines and Therapeutics Revenue & Forecasts
6.2.1 By Region - Global mRNA Cancer Vaccines and Therapeutics Revenue, 2018-2023
6.2.2 By Region - Global mRNA Cancer Vaccines and Therapeutics Revenue, 2024-2030
6.2.3 By Region - Global mRNA Cancer Vaccines and Therapeutics Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America mRNA Cancer Vaccines and Therapeutics Revenue, 2018-2030
6.3.2 US mRNA Cancer Vaccines and Therapeutics Market Size, 2018-2030
6.3.3 Canada mRNA Cancer Vaccines and Therapeutics Market Size, 2018-2030
6.3.4 Mexico mRNA Cancer Vaccines and Therapeutics Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe mRNA Cancer Vaccines and Therapeutics Revenue, 2018-2030
6.4.2 Germany mRNA Cancer Vaccines and Therapeutics Market Size, 2018-2030
6.4.3 France mRNA Cancer Vaccines and Therapeutics Market Size, 2018-2030
6.4.4 U.K. mRNA Cancer Vaccines and Therapeutics Market Size, 2018-2030
6.4.5 Italy mRNA Cancer Vaccines and Therapeutics Market Size, 2018-2030
6.4.6 Russia mRNA Cancer Vaccines and Therapeutics Market Size, 2018-2030
6.4.7 Nordic Countries mRNA Cancer Vaccines and Therapeutics Market Size, 2018-2030
6.4.8 Benelux mRNA Cancer Vaccines and Therapeutics Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia mRNA Cancer Vaccines and Therapeutics Revenue, 2018-2030
6.5.2 China mRNA Cancer Vaccines and Therapeutics Market Size, 2018-2030
6.5.3 Japan mRNA Cancer Vaccines and Therapeutics Market Size, 2018-2030
6.5.4 South Korea mRNA Cancer Vaccines and Therapeutics Market Size, 2018-2030
6.5.5 Southeast Asia mRNA Cancer Vaccines and Therapeutics Market Size, 2018-2030
6.5.6 India mRNA Cancer Vaccines and Therapeutics Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America mRNA Cancer Vaccines and Therapeutics Revenue, 2018-2030
6.6.2 Brazil mRNA Cancer Vaccines and Therapeutics Market Size, 2018-2030
6.6.3 Argentina mRNA Cancer Vaccines and Therapeutics Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa mRNA Cancer Vaccines and Therapeutics Revenue, 2018-2030
6.7.2 Turkey mRNA Cancer Vaccines and Therapeutics Market Size, 2018-2030
6.7.3 Israel mRNA Cancer Vaccines and Therapeutics Market Size, 2018-2030
6.7.4 Saudi Arabia mRNA Cancer Vaccines and Therapeutics Market Size, 2018-2030
6.7.5 UAE mRNA Cancer Vaccines and Therapeutics Market Size, 2018-2030
7 mRNA Cancer Vaccines and Therapeutics Companies Profiles
7.1 Moderna Therapeutics
7.1.1 Moderna Therapeutics Company Summary
7.1.2 Moderna Therapeutics Business Overview
7.1.3 Moderna Therapeutics mRNA Cancer Vaccines and Therapeutics Major Product Offerings
7.1.4 Moderna Therapeutics mRNA Cancer Vaccines and Therapeutics Revenue in Global Market (2018-2023)
7.1.5 Moderna Therapeutics Key News & Latest Developments
7.2 CureVac
7.2.1 CureVac Company Summary
7.2.2 CureVac Business Overview
7.2.3 CureVac mRNA Cancer Vaccines and Therapeutics Major Product Offerings
7.2.4 CureVac mRNA Cancer Vaccines and Therapeutics Revenue in Global Market (2018-2023)
7.2.5 CureVac Key News & Latest Developments
7.3 Translate Bio
7.3.1 Translate Bio Company Summary
7.3.2 Translate Bio Business Overview
7.3.3 Translate Bio mRNA Cancer Vaccines and Therapeutics Major Product Offerings
7.3.4 Translate Bio mRNA Cancer Vaccines and Therapeutics Revenue in Global Market (2018-2023)
7.3.5 Translate Bio Key News & Latest Developments
7.4 BioNTech
7.4.1 BioNTech Company Summary
7.4.2 BioNTech Business Overview
7.4.3 BioNTech mRNA Cancer Vaccines and Therapeutics Major Product Offerings
7.4.4 BioNTech mRNA Cancer Vaccines and Therapeutics Revenue in Global Market (2018-2023)
7.4.5 BioNTech Key News & Latest Developments
7.5 Sangamo Therapeutics
7.5.1 Sangamo Therapeutics Company Summary
7.5.2 Sangamo Therapeutics Business Overview
7.5.3 Sangamo Therapeutics mRNA Cancer Vaccines and Therapeutics Major Product Offerings
7.5.4 Sangamo Therapeutics mRNA Cancer Vaccines and Therapeutics Revenue in Global Market (2018-2023)
7.5.5 Sangamo Therapeutics Key News & Latest Developments
7.6 Argos Therapeutics
7.6.1 Argos Therapeutics Company Summary
7.6.2 Argos Therapeutics Business Overview
7.6.3 Argos Therapeutics mRNA Cancer Vaccines and Therapeutics Major Product Offerings
7.6.4 Argos Therapeutics mRNA Cancer Vaccines and Therapeutics Revenue in Global Market (2018-2023)
7.6.5 Argos Therapeutics Key News & Latest Developments
7.7 In-Cell-Art
7.7.1 In-Cell-Art Company Summary
7.7.2 In-Cell-Art Business Overview
7.7.3 In-Cell-Art mRNA Cancer Vaccines and Therapeutics Major Product Offerings
7.7.4 In-Cell-Art mRNA Cancer Vaccines and Therapeutics Revenue in Global Market (2018-2023)
7.7.5 In-Cell-Art Key News & Latest Developments
7.8 eTheRNA
7.8.1 eTheRNA Company Summary
7.8.2 eTheRNA Business Overview
7.8.3 eTheRNA mRNA Cancer Vaccines and Therapeutics Major Product Offerings
7.8.4 eTheRNA mRNA Cancer Vaccines and Therapeutics Revenue in Global Market (2018-2023)
7.8.5 eTheRNA Key News & Latest Developments
7.9 Ethris
7.9.1 Ethris Company Summary
7.9.2 Ethris Business Overview
7.9.3 Ethris mRNA Cancer Vaccines and Therapeutics Major Product Offerings
7.9.4 Ethris mRNA Cancer Vaccines and Therapeutics Revenue in Global Market (2018-2023)
7.9.5 Ethris Key News & Latest Developments
7.10 Tiba Biotechnology
7.10.1 Tiba Biotechnology Company Summary
7.10.2 Tiba Biotechnology Business Overview
7.10.3 Tiba Biotechnology mRNA Cancer Vaccines and Therapeutics Major Product Offerings
7.10.4 Tiba Biotechnology mRNA Cancer Vaccines and Therapeutics Revenue in Global Market (2018-2023)
7.10.5 Tiba Biotechnology Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
